×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: Sonal Kumar
Institution: Institute of Bioinformatics and Applied Biotechnology (IBAB)
Department: Bioinformatics
Country:
Proposed Analysis: Certain gene targets implicated downstream of estrogen signaling in the brain may be directly responsible for greater cognitive impairment and neuronal atrophy seen in female AD patients. My goal is to identify such AD risk genes by observing mutation profiles seen in male and female samples. The main objectives of the study are outlined below: 1. To understand the disparity in mutation profiles seen within males and females for normal versus disease. 2. To correlate age of onset with variants obtained in the first objective. 3. To identify mutations in the estrogen signalling pathway(s) in the brain that correlate with greater cognitive impairment and neurodegeneration in female AD patients.
Additional Investigators  
Investigator's Name: Bibha Choudhary
Proposed Analysis: Certain gene targets implicated downstream of estrogen signaling in the brain may be directly responsible for greater cognitive impairment and neuronal atrophy seen in female AD patients. My goal is to identify such AD risk genes by observing mutation profiles seen in male and female samples. The main objectives of the study are outlined below: 1. To understand the disparity in mutation profiles seen within males and females for normal versus disease. 2. To correlate age of onset with variants obtained in the first objective. 3. To identify mutations in the estrogen signalling pathway(s) in the brain that correlate with greater cognitive impairment and neurodegeneration in female AD patients.